Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
University of Queensland
Biotech
Ex-GSK vaccine R&D chief to lead new vax venture, launch RSV jab
Emmanuel Hanon, ex-global R&D head for GSK's vaccine division, has been tapped to be CEO of Vicebio, a vaccine developer working on a rival RSV jab.
Max Bayer
Jul 21, 2022 11:05am
A COVID-19 vaccine in a patch rivals shots in mice
Oct 29, 2021 2:00pm
Could I-O drugs get a boost from an existing antipsychotic drug?
Mar 6, 2020 9:30am
Scorpion toxin could inspire non-opioid pain treatments
Aug 23, 2019 8:45am
Cannabidiol shows promise against superbugs
Jun 24, 2019 12:11pm
FierceMedtech’s top 10 reads this year: Theranos exits, and more
Dec 21, 2018 9:00am
